Page last updated: 2024-08-24

5-bromo-4-chloro-3-indolyl beta-galactoside and lomustine

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with lomustine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castro, MG; Darling, JL; Lowenstein, PR; Maleniak, TC1

Other Studies

1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and lomustine

ArticleYear
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
    Cancer gene therapy, 2001, Volume: 8, Issue:8

    Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured

2001